Lennox Gastaut Syndrome News and Research

RSS
Lennox-Gastaut syndrome (LGS) is a severe type of epilepsy characterized by many types of seizures, mainly drop and stiffening seizures. LGS can be a result of malformations in the brain, head injury, perinatal asphyxia, infection in the central nervous system, and inherited metabolic or degenerative disorders.
FDA approves CBD oral solution for treatment of seizures related to tuberous sclerosis complex

FDA approves CBD oral solution for treatment of seizures related to tuberous sclerosis complex

Young Epilepsy welcomes NICE’s approval of CBD as treatment for children with epilepsy

Young Epilepsy welcomes NICE’s approval of CBD as treatment for children with epilepsy

Study may help explain effects of cannabidiol on seizure frequency in Lennox-Gastaut patients

Study may help explain effects of cannabidiol on seizure frequency in Lennox-Gastaut patients

Researchers study cannabis dosage to reduce seizures in children with severe epilepsy

Researchers study cannabis dosage to reduce seizures in children with severe epilepsy

Cannabinoids hold promise in treating children with epilepsy

Cannabinoids hold promise in treating children with epilepsy

The pluses and minuses of allowing medical marijuana at school

The pluses and minuses of allowing medical marijuana at school

FDA approves cannabis based drug for severe form of epilepsy

FDA approves cannabis based drug for severe form of epilepsy

FDA approves new marijuana-based drug to treat rare and severe forms of epilepsy

FDA approves new marijuana-based drug to treat rare and severe forms of epilepsy

FDA approves marijuana based medication for epilepsy treatment

FDA approves marijuana based medication for epilepsy treatment

Cannabidiol shows promise to reduce seizures for people with difficult-to-treat epilepsy

Cannabidiol shows promise to reduce seizures for people with difficult-to-treat epilepsy

Mylan releases generic version of Felbatol Tablets in U.S.

Mylan releases generic version of Felbatol Tablets in U.S.

New technology benefits child suffering from severe form of epilepsy

New technology benefits child suffering from severe form of epilepsy

Upsher-Smith announces FDA approval of sNDA for Qudexy XR extended-release capsules

Upsher-Smith announces FDA approval of sNDA for Qudexy XR extended-release capsules

UK doctors to test cannabis-based medicine for children with severe epilepsy

UK doctors to test cannabis-based medicine for children with severe epilepsy

Researchers identify clear genetic risk factors in patients with severe epilepsy

Researchers identify clear genetic risk factors in patients with severe epilepsy

Study of childhood epilepsies links two new genes to severe forms of disease

Study of childhood epilepsies links two new genes to severe forms of disease

Epilepsy community welcomes IOM's new landmark study report

Epilepsy community welcomes IOM's new landmark study report

Lundbeck announces availability of ONFI Tablets in the U.S.

Lundbeck announces availability of ONFI Tablets in the U.S.

Lundbeck's ONFI receives FDA approval for treating seizures associated with Lennox-Gastaut syndrome

Lundbeck's ONFI receives FDA approval for treating seizures associated with Lennox-Gastaut syndrome

FDA accepts Lundbeck's clobazam NDA for review

FDA accepts Lundbeck's clobazam NDA for review